Government Context
Documents
Following
Sign in
Documents
Documents by topic
Documents by agency
Following
Sign in
Details
Dockets
›
Requests that FDA declare that Rosuvastatin Calcium Tablets, 7.5 mg, 15 mg, 25 mg, 30 mg, and 35 mg, are suitable for submission as an ANDA.
›
Completeness Assessment Correspondence
Completeness Assessment Correspondence
Nonrulemaking
Other
FDA-2026-P-5994-0006
Pharmaceutical Policy
🔔 Subscribe
Document
Details
The document's own metadata, straight from regulations.gov.
Posted
Jun 8, 2026
Agency
Food and Drug Administration (FDA)
